Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Dr. Reddy’s Laboratories, in India, and Merck Serono, a division of Germany’s Merck KGaA, will jointly develop generic biologic, or biosimilar, drugs. They will focus primarily on developing, manufacturing, and selling monoclonal antibodies for oncology purposes. The partners will share R&D costs and divide up worldwide commercial activities. Dr. Reddy’s will handle early product development, including Phase I clinical trials. After that, Merck Serono will assume manufacturing and development through Phase III.
This article has been sent to the following recipient: